Wonlim KRX:005820KOSPI
원림 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days1
DART filings, 7 days0
Articles tracked8since Sep 11
In Q2 2026, Wonlim reported revenue of ₩22.3bn, up 9.9% year on year, and operating profit of ₩789m. Wonlim (원림) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Oct 30 with 1 article.
Wonlim quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩22.3bn | +9.9% | ₩789m margin 3.5% | ₩1.9bn |
| Q1 2026 | ₩20.7bn | -1.0% | ₩1.2bn margin 5.9% | ₩1.2bn |
| Q4 2025 derived | ₩27.5bn | +18.1% | ₩1.4bn margin 5.1% | ₩1.7bn |
| Q3 2025 | ₩21.0bn | +11.7% | ₩1.4bn margin 6.8% | ₩1.8bn |
| Q2 2025 | ₩20.3bn | +2.0% | ₩35m margin 0.2% | ₩393m |
| Q1 2025 | ₩20.9bn | +2.4% | ₩1.6bn margin 7.4% | ₩1.3bn |
| Q4 2024 derived | ₩23.3bn | -10.3% | ₩328m margin 1.4% | ₩1.3bn |
| Q3 2024 | ₩18.8bn | -0.5% | ₩180m margin 1.0% | −₩125m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Wonlim top stories 2 weeks, by number of outlets
- 1
Latest Wonlim news Korean headlines
-
원림, 의료기기 사업·바이오 투자 병행으로 성장동력 다변화
1 more on this story · 1 outlets
- 원림, 의료기기 사업·바이오 투자 병행으로 성장동력 다변화이데일리 · Oct 7 09:15
-
원림, ESG 혁신 TF팀 신설…기업가치 제고
1 more on this story · 1 outlets
- 원림, 지속가능경영 통해 ‘기업가치 제고’…ESG 혁신 TF팀 발족코리아리포트 · Sep 22 12:05